Hereditary Breast & Ovarian Cancer

Hereditary breast and ovarian cancer due to mutations in the brca1 and brca2 genes is the most common cause of hereditary forms of both breast and ovarian cancer. Here are the latest discoveries pertaining to these cancers.

January 9, 2021
Correction
Open Access

Correction to: Prevalence of RECQL germline variants in Pakistani early-onset and familial breast cancer patients

Hereditary Cancer in Clinical Practice
Muhammad Usman RashidUte Hamann
January 14, 2021

Impact of past surgical history on perioperative outcomes in gynecologic surgery

Gynecologic Oncology
Emily M KoLori Cory
January 16, 2021

Double heterozygosity for TP53 and BRCA1 mutations: clinical implications in populations with founder mutations

Breast Cancer Research and Treatment
Hagit ShaniEitan Friedman
January 1, 2021
Open Access

Recent advances in the pathology of heritable gastric cancer syndromes

Histopathology
Irene GulloFátima Carneiro
December 30, 2020

Performance of breast cancer polygenic risk scores in 760 female CHEK2 germline mutation carriers

Journal of the National Cancer Institute
Julika BordeEric Hahnen
January 9, 2021
Review

Preoperative frailty assessment in patients undergoing gynecologic oncology surgery: A systematic review

Gynecologic Oncology
Violante Di DonatoPierluigi Benedetti Panici
December 31, 2020

Total and out-of-pocket costs for PARP inhibitors among insured ovarian cancer patients

Gynecologic Oncology
Margaret I LiangJason D Wright
January 5, 2021
Open Access

The effect of family history on screening procedures and prognosis in breast cancer patients - Results of a large population-based case-control study

The Breast : Official Journal of the European Society of Mastology
Katharina SeiffertIsabell Witzel
January 15, 2021

Integrating PARP inhibitors into the management of breast cancer: where are we?

Chinese Clinical Oncology
Hamdy A AzimHatem Azim
January 12, 2021

#TripleNegativeBreastCancer on Instagram

Health Education & Behavior : the Official Publication of the Society for Public Health Education
Alesha HendersonJeanine P D Guidry
January 6, 2021
Preprint
Open Access

Implementing genomic screening in diverse populations

MedRxiv : the Preprint Server for Health Sciences
Noura S Abul-HusnE. E. Kenny
January 13, 2021
Review

High-risk screening using magnetic resonance imaging

Der Radiologe
Ulrich Bick

Sign up to follow this feed and discover related papers.

Related Feeds

Adenomatous Polyposis Coli

Adenomatous polyposis coli is a protein encoded by the APC gene and acts as a tumor suppressor. Discover the latest research on adenomatous polyposis coli here.

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Breast Cancer: Risk Factors

Breast cancer is a multifactorial disease that is influenced by both environmental and genetic factors. Discover the latest research on the environmental and genetic risk factors for breast cancer here.

Breast Cancer: Therapeutic Approaches

Several different therapeutic approaches are used to treat breast cancer. These include chemotherapy, hormonal therapy, targeted therapy, and Immunotherapy. Discover the latest research on breast cancer therapeutic approaches here.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Carcinoma, Lobular

Lobular carcinoma is an invasive type of breast cancer in which lobules, areas of the breast that produce milk, undergo malignant transformation. Here is the latest research.

Cervical Squamous Cell Carcinoma And Endocervical Adenocarcinoma

The cervix contains two types of cells and when cancer arises from squamous cells within the cervix it is cervical squamous cell carcinoma. The endocervix is located just above the body of the cervix and contains glandular cells. When cancer begins here it is called endocervical adenocarcinoma. Here is the latest research on these two types of cancers.

© 2021 Meta ULC. All rights reserved
/feed-previews/hereditary-breast-ovarian-cancer/ae470ab4-3ff6-4778-93bb-3362417487b7